E88.32 MERRF syndrome

Name of the Condition

• MERRF syndrome

Summary

MERRF syndrome (Myoclonic Epilepsy with Ragged-Red Fibers) is a rare mitochondrial disorder characterized by progressive neurological decline, myoclonus, and muscle weakness. It results from mitochondrial DNA mutations affecting energy production in cells, particularly in the nervous system and muscles. The condition typically presents in childhood or adolescence and follows a variable course, with symptoms worsening over time.

Causes

MERRF syndrome is caused by mutations in mitochondrial DNA, most commonly the A8344G mutation in the MT-TK gene. These mutations disrupt mitochondrial protein synthesis and impair oxidative phosphorylation, leading to energy deficits in cells. The disorder is maternally inherited, as mitochondrial DNA is passed from mother to offspring, though sporadic cases may occur due to de novo mutations.

Risk Factors

• Maternal inheritance of mitochondrial DNA mutations
• Family history of mitochondrial disorders
• Presence of specific mitochondrial DNA mutations (e.g., A8344G)
• Age (symptoms typically onset in childhood or adolescence)

Symptoms

• Myoclonus (sudden, involuntary muscle jerks)
• Generalized epilepsy or seizures
• Ataxia (loss of coordination)
• Muscle weakness and wasting
• Hearing loss
• Cognitive decline or dementia
• Short stature
• Optic atrophy or vision problems

Diagnosis

Diagnosis involves clinical evaluation of neurological symptoms, family history, and specialized testing. Muscle biopsy may reveal ragged-red fibers under microscopy, indicative of mitochondrial dysfunction. Genetic testing confirms mutations in mitochondrial DNA, particularly the MT-TK gene. Additional tests, such as lactate levels or electromyography, may support the diagnosis.

Treatment Options

Treatment focuses on managing symptoms and complications. Antiepileptic drugs control seizures and myoclonus. Physical therapy and assistive devices address muscle weakness and ataxia. Hearing aids or cochlear implants may be used for hearing loss. No cure exists, but supportive care improves quality of life. Experimental therapies targeting mitochondrial function are under investigation.

Prognosis and Follow-Up

Prognosis varies, with some individuals experiencing gradual decline and others maintaining stability for years. Life expectancy may be reduced due to respiratory or cardiac complications. Regular follow-up with neurologists, geneticists, and other specialists is essential to monitor progression and adjust management. Early intervention can mitigate some symptoms.

Complications

• Respiratory failure from muscle weakness
• Cardiac arrhythmias or cardiomyopathy
• Severe cognitive impairment
• Progressive hearing and vision loss
• Malnutrition or feeding difficulties
• Increased risk of infections

Lifestyle & Prevention

• Maintain a balanced diet to support mitochondrial health
• Avoid known mitochondrial toxins (e.g., certain antibiotics)
• Engage in regular, low-impact exercise to preserve muscle function
• Use hearing and vision aids as needed
• Genetic counseling for families to assess inheritance risks

When to Seek Professional Help

Seek immediate medical attention for:

• New or worsening seizures
• Sudden difficulty breathing or swallowing
• Severe confusion or loss of consciousness
• Rapid decline in motor function
• Unexplained weight loss or fatigue

Tips for Medical Coders

Document the presence of myoclonus, epilepsy, and ragged-red fibers on muscle biopsy to support the diagnosis. Note any genetic testing results confirming mitochondrial DNA mutations. Include details of maternal inheritance or family history when available. Ensure coding aligns with the specific mitochondrial DNA mutation identified, as this may impact documentation requirements.